Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-25-058070
Filing Date
2025-04-24
Accepted
2025-04-24 16:17:24
Documents
9

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa_2025.htm DEFA14A 149180
2 GRAPHIC img86371940_0.jpg GRAPHIC 5194
3 GRAPHIC img86371940_1.jpg GRAPHIC 79267
4 GRAPHIC img86371940_2.jpg GRAPHIC 4166
5 GRAPHIC img86371940_3.jpg GRAPHIC 9113
6 GRAPHIC img86371940_4.jpg GRAPHIC 4753
7 GRAPHIC img86371940_5.gif GRAPHIC 757
8 GRAPHIC img86371940_6.jpg GRAPHIC 1019
9 GRAPHIC img86371940_7.jpg GRAPHIC 1019
  Complete submission text file 0000950170-25-058070.txt   295015
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 (617)500-8864
Aura Biosciences, Inc. (Filer) CIK: 0001501796 (see all company filings)

EIN.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40971 | Film No.: 25867568
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)